Ron Ram

Summary

Country: Israel

Publications

  1. doi request reprint Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
    Ron Ram
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Acta Haematol 119:104-7. 2008
  2. doi request reprint Toxicity of autologous hematopoietic cell transplantation in patients with multiple myeloma - comparison between two different induction regimens
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Clin Transplant 26:E549-54. 2012
  3. ncbi request reprint Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial
    Mical Paul
    Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
    Am J Hematol 89:243-8. 2014
  4. doi request reprint High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Am J Hematol 86:657-62. 2011
  5. doi request reprint Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Int J Antimicrob Agents 40:123-6. 2012
  6. pmc Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis
    Ronit Gurion
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Israel
    Haematologica 98:95-102. 2013
  7. doi request reprint The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Leuk Res 37:1057-62. 2013
  8. ncbi request reprint Elevation of CRP precedes clinical suspicion of bloodstream infections in patients undergoing hematopoietic cell transplantation
    Ron Ram
    BMT Unit, Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tiqva, Israel
    J Infect 67:194-8. 2013
  9. doi request reprint Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-disease--systematic review and meta-analysis
    Ron Ram
    Bone Marrow Transplantation Unit, Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel Electronic address
    Leuk Res 38:352-60. 2014
  10. doi request reprint Total therapy-based treatment for multiple myeloma--a single center experience
    Hila Magen-Nativ
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Petah Tiqva, Israel
    Ann Hematol 89:53-9. 2010

Detail Information

Publications23

  1. doi request reprint Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
    Ron Ram
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Acta Haematol 119:104-7. 2008
    ..A comprehensive review of the relevant published data, several possible mechanisms and therapeutic alternatives are suggested...
  2. doi request reprint Toxicity of autologous hematopoietic cell transplantation in patients with multiple myeloma - comparison between two different induction regimens
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Clin Transplant 26:E549-54. 2012
    ....
  3. ncbi request reprint Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial
    Mical Paul
    Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
    Am J Hematol 89:243-8. 2014
    ..Patients reported similar pain and satisfaction scores in both groups. Bolus IV administration of G-CSF results in longer neutropenia duration than SC administration, with no difference in clinical or quality-of-life measures...
  4. doi request reprint High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Am J Hematol 86:657-62. 2011
    ..Extended follow up is needed to evaluate if the superior CCyR and MMolR with higher doses of imatinib will translate to long-term clinical benefit...
  5. doi request reprint Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel
    Int J Antimicrob Agents 40:123-6. 2012
    ..Treatment guidelines should address the antibiotic treatment of breakthrough fever...
  6. pmc Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis
    Ronit Gurion
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv University, Israel
    Haematologica 98:95-102. 2013
    ..Although an advantage is suggested by surrogate parameters, longer follow up is necessary to see if this translates into superior overall survival...
  7. doi request reprint The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Leuk Res 37:1057-62. 2013
    ..PET/CT was beneficial in diagnosing abdominal infections. PET/CT has a potential role in the diagnostic evaluation of patients with persistent febrile neutropenia. ..
  8. ncbi request reprint Elevation of CRP precedes clinical suspicion of bloodstream infections in patients undergoing hematopoietic cell transplantation
    Ron Ram
    BMT Unit, Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tiqva, Israel
    J Infect 67:194-8. 2013
    ..We aimed to examine whether C-reactive protein (CRP) elevation precedes the clinical signs and symptoms of infection among patients undergoing allogeneic hematopoietic cell transplantation (HCT)...
  9. doi request reprint Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-disease--systematic review and meta-analysis
    Ron Ram
    Bone Marrow Transplantation Unit, Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel Electronic address
    Leuk Res 38:352-60. 2014
    ..All other analyzed transplantation outcomes were comparable. We conclude that MMF, compared to methotrexate, is associated with increased severity of acute GVHD. Robustness of these results is hampered by the small number of RCTs. ..
  10. doi request reprint Total therapy-based treatment for multiple myeloma--a single center experience
    Hila Magen-Nativ
    Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Petah Tiqva, Israel
    Ann Hematol 89:53-9. 2010
    ..We conclude that this protocol is effective and rather safe. Further clinical trials should assess which subgroups of patients would benefit most from this approach...
  11. doi request reprint Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Am J Hematol 87:472-8. 2012
    ..53, 95% CI 0.19-1.48). Pediatric-inspired regimens are superior to conventional-adult chemotherapy in AYA ALL patients. Further randomized controlled studies to investigate this approach in adult ALL patients are warranted...
  12. doi request reprint Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience
    Eli Muchtar
    1 Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel 2 Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel 3 Pulmonary Institute, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel 4 Institute of Pathology, Rabin Medical Center, Petah Tikva, Israel 5 Address correspondence to Eli Muchtar, M D, Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel 49100
    Transplantation 96:657-63. 2013
    ..However, there are increasing reports on a late-onset form of PTLD...
  13. doi request reprint Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis
    Ron Ram
    Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Cancer 116:3447-57. 2010
    ..The objective of this study was to compare the various potential therapeutic options for patients who achieved first complete remission...
  14. doi request reprint The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission
    Eli Muchtar
    Department of Medicine E, Beilinson Hospital, Rabin Medical Center, 39 Jabotinski Street, Petah Tikva, Israel, 49100
    Cochrane Database Syst Rev 3:CD009594. 2013
    ..A consensus exists regarding the need for administration of both induction and consolidation treatments, albeit using different approaches. However, there is conflicting evidence for the role of maintenance treatment in APL patients...
  15. doi request reprint Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Am J Hematol 84:247-50. 2009
    ..Patients with potential risk factors like splenomegaly and bone marrow involvement, who develop clinical manifestations compatible with cytokine release syndrome, should be closely monitored for rituximab-associated cytopenia...
  16. doi request reprint ATG plus cyclosporine reduces all-cause mortality in patients with severe aplastic anemia--systematic review and meta-analysis
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Acta Haematol 120:237-43. 2008
    ..Immunosuppression is the therapeutic alternative for patients with aplastic anemia who are ineligible for allogeneic transplant. We aimed to assess the benefit of the combination of antithymocyte globulin (ATG) and cyclosporine (CsA)...
  17. ncbi request reprint Surveillance of infectious complications in hemato-oncological patients
    Ron Ram
    Institute of Hematology, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
    Isr Med Assoc J 11:133-7. 2009
    ..Monitoring the rate of infections in individual centers that treat patients with hematological malignancies is of major importance. However, there are no uniform guidelines for infection surveillance...
  18. doi request reprint Renal failure associated with tyrosine kinase inhibitors--case report and review of the literature
    Anat Gafter-Gvili
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Leuk Res 34:123-7. 2010
    ..The literature reporting on the association between TKIs and renal failure is reviewed and the postulated mechanisms including tubular dysfunction caused by the drug or tumor lysis syndrome are discussed...
  19. doi request reprint Management of aplastic anemia: the role of systematic reviews and meta-analyses
    Anat Gafter-Gvili
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Tel Aviv University, Israel
    Acta Haematol 125:47-54. 2011
    ..Specifically, it focuses on four major therapeutic questions: the roles of alloHCT, IST, hematopoietic growth factors and supportive care...
  20. doi request reprint Trends and challenges in searching for HLA-matched unrelated donors in Israel
    Moshe Israeli
    Tissue Typing Laboratory, Rabin Medical Center, Petach Tikva, Israel
    Hum Immunol 74:942-5. 2013
    ..In conclusion, in spite of the large size of local donor registries, they do not optimally reflect the immunogenetic profiles of patients of ethnic minorities and of pediatric patients...
  21. doi request reprint Allogeneic hematopoietic cell transplantation for adult patients with acute leukemia: the role of meta-analyses
    Ron Ram
    Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Tel Aviv University, Israel
    Acta Haematol 125:39-46. 2011
    ..The aim of this review is to examine the contribution of meta-analyses to the establishment of the role of hematopoietic transplantation for acute leukemia and at the same time to highlight limitations and future directions...
  22. pmc Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future
    Ron Ram
    Bone Marrow Transplantation Unit, Rabin Medical Center, Beilinson Hospital and the Sackler School of Medicine, Tel Aviv University, Israel
    Leuk Lymphoma 54:1591-601. 2013
    ..Here we review the present arsenal of medications used to prevent GVHD, focusing on past experience and the current evidence, and discuss future potential targets. ..
  23. ncbi request reprint The late adverse events of rituximab therapy--rare but there!
    Ron Ram
    Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
    Leuk Lymphoma 50:1083-95. 2009
    ..Possible mechanisms involved in rituximab-associated complications and the pathogenesis of these adverse effects are reviewed and discussed. Evidence based graded recommendations for the management of these adverse effects are proposed...